🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested
To demonstrate that the efficacy of secukinumab 300 mg at Week 16 was super...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-06-27
Trial ID
NCT02798211
Treatments Being Tested
This study will assess the safety and efficacy of secukinumab compared to p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-06
Trial ID
NCT01365455
Treatments Being Tested
The study will assess the safety and efficacy of intravenous (10mg/kg) and ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-12
Trial ID
NCT01412944
Treatments Being Tested
The aim of this study was to assess the therapeutic efficacy of secukinumab...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2020-02-19
Trial ID
NCT04237116
Treatments Being Tested
Given the role of IL-17 in the development of entheseal-driven pathology, a...
Status
Unknown
Location
Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2021-07-15
Trial ID
NCT04967950
Treatments Being Tested
This study will assess the safety and efficacy of AIN457 as adjunctive ther...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-04
Trial ID
NCT01095250
The purpose of this study was to demonstrate efficacy including effect on i...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-08-31
Trial ID
NCT02404350
Treatments Being Tested
This study will provide patients who have completed the AIN457 Phase II and...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01327664
Treatments Being Tested
Demonstrate superiority of secukinumab over ustekinumab in treatment of mod...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-06-22
Trial ID
NCT02826603
Treatments Being Tested